Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|June 2, 2015
- Pharmaceutical Technology-06-02-2015
- Volume 39
- Issue 6
Four-Axis Robot Eliminates the Need for Manual Drift Correction
Thermo Scientific’s Spinnaker Smart Laboratory Robot, featuring Thermo Scientific Momentum 4 software, is designed to eliminate the need for manual correction of drift by automatically compensating for positional variations.
Thermo Scientific’s Spinnaker Smart Laboratory Robot, featuring Thermo Scientific Momentum 4 software, is designed to eliminate the need for manual correction of drift by automatically compensating for positional variations. The learning robot features built-in vision, which can be used as a bar code reader for confirmation of sample identification.
The system’s four-axis SCARA, or “selective compliance articulated robot arm,” increases the automatic workflow. Positioning can be achieved during teaching or integrating instruments with flexible arm reach, infinite rotation, and full gravity-neutral joints. The robot also supports a variety of third-party instruments and peripherals.
Thermo Scientific
Articles in this issue
over 11 years ago
Another In-House Operation Gets Outsourcedover 11 years ago
Quality Systems Key to Lifecycle Drug Managementover 11 years ago
Designing Clean Zonesover 11 years ago
New Ways Around Hazardous Reagent Chemistryover 11 years ago
Industry Expert Q&A with David Fitzhenryover 11 years ago
Unlocking the Vast Potential of PAT in Solid-Dosage Manufacturingover 11 years ago
Top Trends in Biopharmaceutical Manufacturing: 2015over 11 years ago
Preventing Common Mistakes in Automated WashingRelated to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.